Del Carmen Jeffrey

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Del Carmen Jeffrey's trades of Catalyst Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
236.94
Quantity 74,604
Value US$2,312,203
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-28 2025-11-26
S Sale
97,089 +42.4%
261.70
US$3,466,388 		97,089 +42.4% 261.70 US$3,466,388
2025-11-26 2025-11-26
PrS Proposed sale
74,604
236.94
US$2,312,203 		74,604 236.94 US$2,312,203
2025-03-05 2025-03-03
S Sale
94,523 -39.9%
354.62
US$2,843,736 		94,523 -39.9% 354.62 US$2,843,736
2025-03-03 2025-03-03
PrS Proposed sale
30,423
22.89
US$696,382 		30,423 22.89 US$696,382
2024-08-13 2024-08-09
S Sale
30,000 -70.8%
18.42
US$552,600 		30,000 -70.8% 18.42 US$552,600
2024-08-13 2024-08-09
S Sale
6,058 -32.9%
18.44
US$111,710 		6,058 -32.9% 18.44 US$111,710
2024-08-09 2024-08-09
PrS Proposed sale
36,058
18.42
US$664,348 		36,058 18.42 US$664,348
2024-06-11 2024-06-07
S Sale
7,541 -29.0%
16.07
US$121,184 		7,541 -29.0% 16.07 US$121,184
2024-06-07 2024-06-07
PrS Proposed sale
7,541
16.07
US$121,184 		7,541 16.07 US$121,184
2023-03-30 2023-03-29
S Sale
19,017 -71.6%
16.69
US$317,394 		19,017 -71.6% 16.69 US$317,394
2023-03-30 2023-03-29
S Sale
20,983 -73.6%
16.70
US$350,416 		20,983 -73.6% 16.70 US$350,416
2022-11-15 2022-11-11
S Sale
19,017 -100.0%
15.46
US$294,022 		19,017 -100.0% 15.46 US$294,022
2022-11-15 2022-11-11
S Sale
120,000 -100.0%
16.23
US$1,947,360 		120,000 -100.0% 16.23 US$1,947,360